Neuromuscular blocker/paralytic, adverse effect: Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "== Related Articles == {{Related Articles}} " to "== Related CCI Codes == == Related Articles == {{Related Articles}} " |
No edit summary |
||
| (20 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle = | | OldDxArticle = | ||
| CurrentStatus = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = | | InitialEditorAssigned = not assigned | ||
}} | }} | ||
{{ICD10 dx | {{ICD10 dx | ||
| Line 9: | Line 9: | ||
| BugRequired= | | BugRequired= | ||
}} | }} | ||
{{ICD10 category|Healthcare contact}}{{ICD10 category| | {{ICD10 category|Healthcare contact}}{{ICD10 category|Allergy}}{{ICD10 category|Adverse effect}} | ||
== Additional Info == | |||
'''Includes''' | |||
{ | *epidural bupivicaine | ||
*succinylcholine | |||
*rocuronium | |||
* Baclofen- classified as an antispasticity agent that acts centrally by enhancing the effect of GABA in the CNS | |||
{{ICD10 Guideline adverse effect}} | |||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == | ||
* [[Neuromuscular blocker/paralytic, overdose/toxicity]] | |||
{ | {{ListICD10Category | categoryName = Adverse effect}} | ||
* [[Anaphylactic reaction (anaphylaxis)]] | |||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
( | * [[Anaphylactic reaction (anaphylaxis)]] | ||
* [[ Allergic reaction (allergy), NOS]] | |||
* [[Skin rash, drug-induced (drug eruption)]] | |||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} | ||